Search

Your search keyword '"Rebecca, Vito W."' showing total 308 results
Start Over Author "Rebecca, Vito W."
308 results on '"Rebecca, Vito W."'

3. ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanoma

Author

Jagirdar, Kasturee, Portuallo, Marie E., Wei, Meihan, Wilhide, Matthew, Bravo Narula, Jeremy A., Robertson, Bailey M., Alicea, Gretchen M., Aguh, Crystal, Xiao, Min, Godok, Tetiana, Fingerman, Dylan, Brown, Gregory Schuyler, Herlyn, Meenhard, Elad, Vissy M., Guo, Xinyu, Toska, Eneda, Zabransky, Daniel J., Wubbenhorst, Bradley, Nathanson, Katherine L., Kwatra, Shawn, Goyal, Yogesh, Ji, Hongkai, Liu, Qin, and Rebecca, Vito W.

Published
2024
Full Text
View/download PDF

5. Methylation of the chromatin modifier KMT2D by SMYD2 contributes to therapeutic response in hormone-dependent breast cancer

Author

Blawski, Ryan, Vokshi, Bujamin H., Guo, Xinyu, Kittane, Srushti, Sallaku, Mirna, Chen, Wanlu, Gjyzari, Martina, Cheung, Tony, Zhang, Yuhan, Simpkins, Christopher, Zhou, Weiqiang, Kulick, Amanda, Zhao, Peihua, Wei, Meihan, Shivashankar, Pranavkrishna, Prioleau, Tatiana, Razavi, Pedram, Koche, Richard, Rebecca, Vito W., de Stanchina, Elisa, Castel, Pau, Chan, Ho Man, Scaltriti, Maurizio, Cocco, Emiliano, Ji, Hongkai, Luo, Minkui, and Toska, Eneda

Published
2024
Full Text
View/download PDF

6. Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy.

Author

Somasundaram, Rajasekharan, Connelly, Thomas, Choi, Robin, Choi, Hyeree, Samarkina, Anastasia, Li, Ling, Gregorio, Elizabeth, Chen, Yeqing, Thakur, Rohit, Abdel-Mohsen, Mohamed, Beqiri, Marilda, Kiernan, Meaghan, Perego, Michela, Wang, Fang, Xiao, Min, Brafford, Patricia, Yang, Xue, Xu, Xiaowei, Secreto, Anthony, Danet-Desnoyers, Gwenn, Traum, Daniel, Kaestner, Klaus H, Huang, Alexander C, Hristova, Denitsa, Wang, Joshua, Fukunaga-Kalabis, Mizuho, Krepler, Clemens, Ping-Chen, Fang, Zhou, Xiangyang, Gutierrez, Alexis, Rebecca, Vito W, Vonteddu, Prashanthi, Dotiwala, Farokh, Bala, Shashi, Majumdar, Sonali, Dweep, Harsh, Wickramasinghe, Jayamanna, Kossenkov, Andrew V, Reyes-Arbujas, Jorge, Santiago, Kenisha, Nguyen, Tran, Griss, Johannes, Keeney, Frederick, Hayden, James, Gavin, Brian J, Weiner, David, Montaner, Luis J, Liu, Qin, Peiffer, Lukas, Becker, Jürgen, Burton, Elizabeth M, Davies, Michael A, Tetzlaff, Michael T, Muthumani, Kar, Wargo, Jennifer A, Gabrilovich, Dmitry, and Herlyn, Meenhard

Subjects
B-Lymphocytes, T-Lymphocytes, Lymphocytes, Tumor-Infiltrating, Mast Cells, Animals, Mice, Transgenic, Humans, Melanoma, Drug Resistance, Neoplasm, Programmed Cell Death 1 Receptor, Sunitinib, Immune Checkpoint Inhibitors
Abstract

Anti-PD-1 therapy is used as a front-line treatment for many cancers, but mechanistic insight into this therapy resistance is still lacking. Here we generate a humanized (Hu)-mouse melanoma model by injecting fetal liver-derived CD34+ cells and implanting autologous thymus in immune-deficient NOD-scid IL2Rγnull (NSG) mice. Reconstituted Hu-mice are challenged with HLA-matched melanomas and treated with anti-PD-1, which results in restricted tumor growth but not complete regression. Tumor RNA-seq, multiplexed imaging and immunohistology staining show high expression of chemokines, as well as recruitment of FOXP3+ Treg and mast cells, in selective tumor regions. Reduced HLA-class I expression and CD8+/Granz B+ T cells homeostasis are observed in tumor regions where FOXP3+ Treg and mast cells co-localize, with such features associated with resistance to anti-PD-1 treatment. Combining anti-PD-1 with sunitinib or imatinib results in the depletion of mast cells and complete regression of tumors. Our results thus implicate mast cell depletion for improving the efficacy of anti-PD-1 therapy.

Published
2021

7. Stromal changes in the aged lung induce an emergence from melanoma dormancy

Author

Fane, Mitchell E., Chhabra, Yash, Alicea, Gretchen M., Maranto, Devon A., Douglass, Stephen M., Webster, Marie R., Rebecca, Vito W., Marino, Gloria E., Almeida, Filipe, Ecker, Brett L., Zabransky, Daniel J., Hüser, Laura, Beer, Thomas, Tang, Hsin-Yao, Kossenkov, Andrew, Herlyn, Meenhard, Speicher, David W., Xu, Wei, Xu, Xiaowei, Jaffee, Elizabeth M., Aguirre-Ghiso, Julio A., and Weeraratna, Ashani T.

Published
2022
Full Text
View/download PDF

8. Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma

Author

Capparelli, Claudia, Purwin, Timothy J., Glasheen, McKenna, Caksa, Signe, Tiago, Manoela, Wilski, Nicole, Pomante, Danielle, Rosenbaum, Sheera, Nguyen, Mai Q., Cai, Weijia, Franco-Barraza, Janusz, Zheng, Richard, Kumar, Gaurav, Chervoneva, Inna, Shimada, Ayako, Rebecca, Vito W., Snook, Adam E., Hookim, Kim, Xu, Xiaowei, Cukierman, Edna, Herlyn, Meenhard, and Aplin, Andrew E.

Published
2022
Full Text
View/download PDF

9. Persister state-directed transitioning and vulnerability in melanoma

Author

Chauvistré, Heike, Shannan, Batool, Daignault-Mill, Sheena M., Ju, Robert J., Picard, Daniel, Egetemaier, Stefanie, Váraljai, Renáta, Gibhardt, Christine S., Sechi, Antonio, Kaschani, Farnusch, Keminer, Oliver, Stehbens, Samantha J., Liu, Qin, Yin, Xiangfan, Jeyakumar, Kirujan, Vogel, Felix C. E., Krepler, Clemens, Rebecca, Vito W., Kubat, Linda, Lueong, Smiths S., Forster, Jan, Horn, Susanne, Remke, Marc, Ehrmann, Michael, Paschen, Annette, Becker, Jürgen C., Helfrich, Iris, Rauh, Daniel, Kaiser, Markus, Gul, Sheraz, Herlyn, Meenhard, Bogeski, Ivan, Rodríguez-López, José Neptuno, Haass, Nikolas K., Schadendorf, Dirk, and Roesch, Alexander

Published
2022
Full Text
View/download PDF

10. Targeting the cyclin-dependent kinase 5 in metastatic melanoma

Author

Sharma, Samanta, Zhang, Tian, Michowski, Wojciech, Rebecca, Vito W., Xiao, Min, Ferretti, Roberta, Suski, Jan M., Bronson, Roderick T., Paulo, Joao A., Frederick, Dennie, Fassl, Anne, Boland, Genevieve M., Geng, Yan, Lees, Jacqueline A., Medema, Rene H., Herlyn, Meenhard, Gygi, Steven P., and Sicinski, Piotr

Published
2020

12. Engineering self-propelled tumor-infiltrating CAR T cells using synthetic velocity receptors

Author

Johnston, Adrian C., primary, Alicea, Gretchen M., additional, Lee, Cameron C., additional, Patel, Payal V., additional, Hanna, Eban A., additional, Vaz, Eduarda, additional, Forjaz, Andre, additional, Wan, Zeqi, additional, Nair, Praful R., additional, Lim, Yeongseo, additional, Chen, Tina, additional, Du, Wenxuan, additional, Kim, Dongjoo, additional, Nichakawade, Tushar D., additional, Rebecca, Vito W., additional, Bonifant, Challice L., additional, Fan, Rong, additional, Kiemen, Ashley L., additional, Wu, Pei-Hsun, additional, and Wirtz, Denis, additional

Published
2023
Full Text
View/download PDF

13. ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanoma

Author

Jagirdar, Kasturee, primary, Portuallo, Marie E., additional, Wei, Meihan, additional, Wilhide, Matthew, additional, Bravo Narula, Jeremy A., additional, Robertson, Bailey M., additional, Alicea, Gretchen M., additional, Aguh, Crystal, additional, Xiao, Min, additional, Godok, Tetiana, additional, Fingerman, Dylan, additional, Brown, Gregory Schuyler, additional, Herlyn, Meenhard, additional, Elad, Vissy M., additional, Guo, Xinyu, additional, Toska, Eneda, additional, Zabransky, Daniel J., additional, Wubbenhorst, Bradley, additional, Nathanson, Katherine L., additional, Kwatra, Shawn, additional, Goyal, Yogesh, additional, Ji, Hongkai, additional, Liu, Qin, additional, and Rebecca, Vito W., additional

Published
2023
Full Text
View/download PDF

24. Diversity, equity, and inclusion in the melanoma research community

Author

Portuallo, Marie E., primary, Lu, David Y., additional, Alicea, Gretchen M., additional, Bolling, Joel, additional, Lee, Rebecca, additional, McQuade, Jennifer, additional, Warner, Allison Betof, additional, Davies, Michael, additional, Weeraratna, Ashani, additional, Villanueva, Jessie, additional, and Rebecca, Vito W., additional

Published
2023
Full Text
View/download PDF

25. Supplementary Data from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2

Author

Alicea, Gretchen M., primary, Rebecca, Vito W., primary, Goldman, Aaron R., primary, Fane, Mitchell E., primary, Douglass, Stephen M., primary, Behera, Reeti, primary, Webster, Marie R., primary, Kugel, Curtis H., primary, Ecker, Brett L., primary, Caino, M. Cecilia, primary, Kossenkov, Andrew V., primary, Tang, Hsin-Yao, primary, Frederick, Dennie T., primary, Flaherty, Keith T., primary, Xu, Xiaowei, primary, Liu, Qin, primary, Gabrilovich, Dmitry I., primary, Herlyn, Meenhard, primary, Blair, Ian A., primary, Schug, Zachary T., primary, Speicher, David W., primary, and Weeraratna, Ashani T., primary

Published
2023
Full Text
View/download PDF

26. Supplementary Movie 1 from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2

Author

Alicea, Gretchen M., primary, Rebecca, Vito W., primary, Goldman, Aaron R., primary, Fane, Mitchell E., primary, Douglass, Stephen M., primary, Behera, Reeti, primary, Webster, Marie R., primary, Kugel, Curtis H., primary, Ecker, Brett L., primary, Caino, M. Cecilia, primary, Kossenkov, Andrew V., primary, Tang, Hsin-Yao, primary, Frederick, Dennie T., primary, Flaherty, Keith T., primary, Xu, Xiaowei, primary, Liu, Qin, primary, Gabrilovich, Dmitry I., primary, Herlyn, Meenhard, primary, Blair, Ian A., primary, Schug, Zachary T., primary, Speicher, David W., primary, and Weeraratna, Ashani T., primary

Published
2023
Full Text
View/download PDF

27. Supplementary Movie 2 from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2

Author

Alicea, Gretchen M., primary, Rebecca, Vito W., primary, Goldman, Aaron R., primary, Fane, Mitchell E., primary, Douglass, Stephen M., primary, Behera, Reeti, primary, Webster, Marie R., primary, Kugel, Curtis H., primary, Ecker, Brett L., primary, Caino, M. Cecilia, primary, Kossenkov, Andrew V., primary, Tang, Hsin-Yao, primary, Frederick, Dennie T., primary, Flaherty, Keith T., primary, Xu, Xiaowei, primary, Liu, Qin, primary, Gabrilovich, Dmitry I., primary, Herlyn, Meenhard, primary, Blair, Ian A., primary, Schug, Zachary T., primary, Speicher, David W., primary, and Weeraratna, Ashani T., primary

Published
2023
Full Text
View/download PDF

28. Data from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2

Author

Alicea, Gretchen M., primary, Rebecca, Vito W., primary, Goldman, Aaron R., primary, Fane, Mitchell E., primary, Douglass, Stephen M., primary, Behera, Reeti, primary, Webster, Marie R., primary, Kugel, Curtis H., primary, Ecker, Brett L., primary, Caino, M. Cecilia, primary, Kossenkov, Andrew V., primary, Tang, Hsin-Yao, primary, Frederick, Dennie T., primary, Flaherty, Keith T., primary, Xu, Xiaowei, primary, Liu, Qin, primary, Gabrilovich, Dmitry I., primary, Herlyn, Meenhard, primary, Blair, Ian A., primary, Schug, Zachary T., primary, Speicher, David W., primary, and Weeraratna, Ashani T., primary

Published
2023
Full Text
View/download PDF

30. Supplementary Video 7 from Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling

Author

Adamopoulos, Christos, primary, Ahmed, Tamer A., primary, Tucker, Maxwell R., primary, Ung, Peter M.U., primary, Xiao, Min, primary, Karoulia, Zoi, primary, Amabile, Angelo, primary, Wu, Xuewei, primary, Aaronson, Stuart A., primary, Ang, Celina, primary, Rebecca, Vito W., primary, Brown, Brian D., primary, Schlessinger, Avner, primary, Herlyn, Meenhard, primary, Wang, Qi, primary, Shaw, David E., primary, and Poulikakos, Poulikos I., primary

Published
2023
Full Text
View/download PDF

31. Data from ER Translocation of the MAPK Pathway Drives Therapy Resistance in BRAF-Mutant Melanoma

Author

Ojha, Rani, primary, Leli, Nektaria M., primary, Onorati, Angelique, primary, Piao, Shengfu, primary, Verginadis, Ioannis I., primary, Tameire, Feven, primary, Rebecca, Vito W., primary, Chude, Cynthia I., primary, Murugan, Sengottuvelan, primary, Fennelly, Colin, primary, Noguera-Ortega, Estela, primary, Chu, Charleen T., primary, Liu, Shujing, primary, Xu, Xiaowei, primary, Krepler, Clemens, primary, Xiao, Min, primary, Xu, Wei, primary, Wei, Zhi, primary, Frederick, Dennie T., primary, Boland, Genevieve, primary, Mitchell, Tara C., primary, Karakousis, Giorgos C., primary, Schuchter, Lynn M., primary, Flaherty, Keith T., primary, Zhang, Gao, primary, Herlyn, Meenhard, primary, Koumenis, Constantinos, primary, and Amaravadi, Ravi K., primary

Published
2023
Full Text
View/download PDF

33. Supplementary Figures from Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling

Author

Adamopoulos, Christos, primary, Ahmed, Tamer A., primary, Tucker, Maxwell R., primary, Ung, Peter M.U., primary, Xiao, Min, primary, Karoulia, Zoi, primary, Amabile, Angelo, primary, Wu, Xuewei, primary, Aaronson, Stuart A., primary, Ang, Celina, primary, Rebecca, Vito W., primary, Brown, Brian D., primary, Schlessinger, Avner, primary, Herlyn, Meenhard, primary, Wang, Qi, primary, Shaw, David E., primary, and Poulikakos, Poulikos I., primary

Published
2023
Full Text
View/download PDF

35. Supplementary Video 2 from Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling

Author

Adamopoulos, Christos, primary, Ahmed, Tamer A., primary, Tucker, Maxwell R., primary, Ung, Peter M.U., primary, Xiao, Min, primary, Karoulia, Zoi, primary, Amabile, Angelo, primary, Wu, Xuewei, primary, Aaronson, Stuart A., primary, Ang, Celina, primary, Rebecca, Vito W., primary, Brown, Brian D., primary, Schlessinger, Avner, primary, Herlyn, Meenhard, primary, Wang, Qi, primary, Shaw, David E., primary, and Poulikakos, Poulikos I., primary

Published
2023
Full Text
View/download PDF

36. Supplementary Movie 2 (SM2) from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2

Author

Alicea, Gretchen M., primary, Rebecca, Vito W., primary, Goldman, Aaron R., primary, Fane, Mitchell E., primary, Douglass, Stephen M., primary, Behera, Reeti, primary, Webster, Marie R., primary, Kugel, Curtis H., primary, Ecker, Brett L., primary, Caino, M. Cecilia, primary, Kossenkov, Andrew V., primary, Tang, Hsin-Yao, primary, Frederick, Dennie T., primary, Flaherty, Keith T., primary, Xu, Xiaowei, primary, Liu, Qin, primary, Gabrilovich, Dmitry I., primary, Herlyn, Meenhard, primary, Blair, Ian A., primary, Schug, Zachary T., primary, Speicher, David W., primary, and Weeraratna, Ashani T., primary

Published
2023
Full Text
View/download PDF

37. Supplementary Video 6 from Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling

Author

Adamopoulos, Christos, primary, Ahmed, Tamer A., primary, Tucker, Maxwell R., primary, Ung, Peter M.U., primary, Xiao, Min, primary, Karoulia, Zoi, primary, Amabile, Angelo, primary, Wu, Xuewei, primary, Aaronson, Stuart A., primary, Ang, Celina, primary, Rebecca, Vito W., primary, Brown, Brian D., primary, Schlessinger, Avner, primary, Herlyn, Meenhard, primary, Wang, Qi, primary, Shaw, David E., primary, and Poulikakos, Poulikos I., primary

Published
2023
Full Text
View/download PDF

38. Supplementary Figures from ER Translocation of the MAPK Pathway Drives Therapy Resistance in BRAF-Mutant Melanoma

Author

Ojha, Rani, primary, Leli, Nektaria M., primary, Onorati, Angelique, primary, Piao, Shengfu, primary, Verginadis, Ioannis I., primary, Tameire, Feven, primary, Rebecca, Vito W., primary, Chude, Cynthia I., primary, Murugan, Sengottuvelan, primary, Fennelly, Colin, primary, Noguera-Ortega, Estela, primary, Chu, Charleen T., primary, Liu, Shujing, primary, Xu, Xiaowei, primary, Krepler, Clemens, primary, Xiao, Min, primary, Xu, Wei, primary, Wei, Zhi, primary, Frederick, Dennie T., primary, Boland, Genevieve, primary, Mitchell, Tara C., primary, Karakousis, Giorgos C., primary, Schuchter, Lynn M., primary, Flaherty, Keith T., primary, Zhang, Gao, primary, Herlyn, Meenhard, primary, Koumenis, Constantinos, primary, and Amaravadi, Ravi K., primary

Published
2023
Full Text
View/download PDF

39. Supplementary Video 5 from Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling

Author

Adamopoulos, Christos, primary, Ahmed, Tamer A., primary, Tucker, Maxwell R., primary, Ung, Peter M.U., primary, Xiao, Min, primary, Karoulia, Zoi, primary, Amabile, Angelo, primary, Wu, Xuewei, primary, Aaronson, Stuart A., primary, Ang, Celina, primary, Rebecca, Vito W., primary, Brown, Brian D., primary, Schlessinger, Avner, primary, Herlyn, Meenhard, primary, Wang, Qi, primary, Shaw, David E., primary, and Poulikakos, Poulikos I., primary

Published
2023
Full Text
View/download PDF

40. Supplemental Figures S1-S7 and Supplemental Table S1 from A Unified Approach to Targeting the Lysosome's Degradative and Growth Signaling Roles

Author

Rebecca, Vito W., primary, Nicastri, Michael C., primary, McLaughlin, Noel, primary, Fennelly, Colin, primary, McAfee, Quentin, primary, Ronghe, Amruta, primary, Nofal, Michel, primary, Lim, Chun-Yan, primary, Witze, Eric, primary, Chude, Cynthia I., primary, Zhang, Gao, primary, Alicea, Gretchen M., primary, Piao, Shengfu, primary, Murugan, Sengottuvelan, primary, Ojha, Rani, primary, Levi, Samuel M., primary, Wei, Zhi, primary, Barber-Rotenberg, Julie S., primary, Murphy, Maureen E., primary, Mills, Gordon B., primary, Lu, Yiling, primary, Rabinowitz, Joshua, primary, Marmorstein, Ronen, primary, Liu, Qin, primary, Liu, Shujing, primary, Xu, Xiaowei, primary, Herlyn, Meenhard, primary, Zoncu, Roberto, primary, Brady, Donita C., primary, Speicher, David W., primary, Winkler, Jeffrey D., primary, and Amaravadi, Ravi K., primary

Published
2023
Full Text
View/download PDF

41. Supplementary Figures S1-S4 from PPT1 Promotes Tumor Growth and Is the Molecular Target of Chloroquine Derivatives in Cancer

Author

Rebecca, Vito W., primary, Nicastri, Michael C., primary, Fennelly, Colin, primary, Chude, Cynthia I., primary, Barber-Rotenberg, Julie S., primary, Ronghe, Amruta, primary, McAfee, Quentin, primary, McLaughlin, Noel P., primary, Zhang, Gao, primary, Goldman, Aaron R., primary, Ojha, Rani, primary, Piao, Shengfu, primary, Noguera-Ortega, Estela, primary, Martorella, Alessandra, primary, Alicea, Gretchen M., primary, Lee, Jennifer J., primary, Schuchter, Lynn M., primary, Xu, Xiaowei, primary, Herlyn, Meenhard, primary, Marmorstein, Ronen, primary, Gimotty, Phyllis A., primary, Speicher, David W., primary, Winkler, Jeffrey D., primary, and Amaravadi, Ravi K., primary

Published
2023
Full Text
View/download PDF

42. Data from A Unified Approach to Targeting the Lysosome's Degradative and Growth Signaling Roles

Author

Rebecca, Vito W., primary, Nicastri, Michael C., primary, McLaughlin, Noel, primary, Fennelly, Colin, primary, McAfee, Quentin, primary, Ronghe, Amruta, primary, Nofal, Michel, primary, Lim, Chun-Yan, primary, Witze, Eric, primary, Chude, Cynthia I., primary, Zhang, Gao, primary, Alicea, Gretchen M., primary, Piao, Shengfu, primary, Murugan, Sengottuvelan, primary, Ojha, Rani, primary, Levi, Samuel M., primary, Wei, Zhi, primary, Barber-Rotenberg, Julie S., primary, Murphy, Maureen E., primary, Mills, Gordon B., primary, Lu, Yiling, primary, Rabinowitz, Joshua, primary, Marmorstein, Ronen, primary, Liu, Qin, primary, Liu, Shujing, primary, Xu, Xiaowei, primary, Herlyn, Meenhard, primary, Zoncu, Roberto, primary, Brady, Donita C., primary, Speicher, David W., primary, Winkler, Jeffrey D., primary, and Amaravadi, Ravi K., primary

Published
2023
Full Text
View/download PDF

43. Supplementary Movie 1 (SM1) from Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2

Author

Alicea, Gretchen M., primary, Rebecca, Vito W., primary, Goldman, Aaron R., primary, Fane, Mitchell E., primary, Douglass, Stephen M., primary, Behera, Reeti, primary, Webster, Marie R., primary, Kugel, Curtis H., primary, Ecker, Brett L., primary, Caino, M. Cecilia, primary, Kossenkov, Andrew V., primary, Tang, Hsin-Yao, primary, Frederick, Dennie T., primary, Flaherty, Keith T., primary, Xu, Xiaowei, primary, Liu, Qin, primary, Gabrilovich, Dmitry I., primary, Herlyn, Meenhard, primary, Blair, Ian A., primary, Schug, Zachary T., primary, Speicher, David W., primary, and Weeraratna, Ashani T., primary

Published
2023
Full Text
View/download PDF

44. Supplementary Video 4 from Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling

Author

Adamopoulos, Christos, primary, Ahmed, Tamer A., primary, Tucker, Maxwell R., primary, Ung, Peter M.U., primary, Xiao, Min, primary, Karoulia, Zoi, primary, Amabile, Angelo, primary, Wu, Xuewei, primary, Aaronson, Stuart A., primary, Ang, Celina, primary, Rebecca, Vito W., primary, Brown, Brian D., primary, Schlessinger, Avner, primary, Herlyn, Meenhard, primary, Wang, Qi, primary, Shaw, David E., primary, and Poulikakos, Poulikos I., primary

Published
2023
Full Text
View/download PDF

45. Chemical Methods from A Unified Approach to Targeting the Lysosome's Degradative and Growth Signaling Roles

Author

Rebecca, Vito W., primary, Nicastri, Michael C., primary, McLaughlin, Noel, primary, Fennelly, Colin, primary, McAfee, Quentin, primary, Ronghe, Amruta, primary, Nofal, Michel, primary, Lim, Chun-Yan, primary, Witze, Eric, primary, Chude, Cynthia I., primary, Zhang, Gao, primary, Alicea, Gretchen M., primary, Piao, Shengfu, primary, Murugan, Sengottuvelan, primary, Ojha, Rani, primary, Levi, Samuel M., primary, Wei, Zhi, primary, Barber-Rotenberg, Julie S., primary, Murphy, Maureen E., primary, Mills, Gordon B., primary, Lu, Yiling, primary, Rabinowitz, Joshua, primary, Marmorstein, Ronen, primary, Liu, Qin, primary, Liu, Shujing, primary, Xu, Xiaowei, primary, Herlyn, Meenhard, primary, Zoncu, Roberto, primary, Brady, Donita C., primary, Speicher, David W., primary, Winkler, Jeffrey D., primary, and Amaravadi, Ravi K., primary

Published
2023
Full Text
View/download PDF

46. Data from Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling

Author

Adamopoulos, Christos, primary, Ahmed, Tamer A., primary, Tucker, Maxwell R., primary, Ung, Peter M.U., primary, Xiao, Min, primary, Karoulia, Zoi, primary, Amabile, Angelo, primary, Wu, Xuewei, primary, Aaronson, Stuart A., primary, Ang, Celina, primary, Rebecca, Vito W., primary, Brown, Brian D., primary, Schlessinger, Avner, primary, Herlyn, Meenhard, primary, Wang, Qi, primary, Shaw, David E., primary, and Poulikakos, Poulikos I., primary

Published
2023
Full Text
View/download PDF

47. Supplementary Movie 1 from ER Translocation of the MAPK Pathway Drives Therapy Resistance in BRAF-Mutant Melanoma

Author

Ojha, Rani, primary, Leli, Nektaria M., primary, Onorati, Angelique, primary, Piao, Shengfu, primary, Verginadis, Ioannis I., primary, Tameire, Feven, primary, Rebecca, Vito W., primary, Chude, Cynthia I., primary, Murugan, Sengottuvelan, primary, Fennelly, Colin, primary, Noguera-Ortega, Estela, primary, Chu, Charleen T., primary, Liu, Shujing, primary, Xu, Xiaowei, primary, Krepler, Clemens, primary, Xiao, Min, primary, Xu, Wei, primary, Wei, Zhi, primary, Frederick, Dennie T., primary, Boland, Genevieve, primary, Mitchell, Tara C., primary, Karakousis, Giorgos C., primary, Schuchter, Lynn M., primary, Flaherty, Keith T., primary, Zhang, Gao, primary, Herlyn, Meenhard, primary, Koumenis, Constantinos, primary, and Amaravadi, Ravi K., primary

Published
2023
Full Text
View/download PDF

48. Supplementary Tables from Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling

Author

Adamopoulos, Christos, primary, Ahmed, Tamer A., primary, Tucker, Maxwell R., primary, Ung, Peter M.U., primary, Xiao, Min, primary, Karoulia, Zoi, primary, Amabile, Angelo, primary, Wu, Xuewei, primary, Aaronson, Stuart A., primary, Ang, Celina, primary, Rebecca, Vito W., primary, Brown, Brian D., primary, Schlessinger, Avner, primary, Herlyn, Meenhard, primary, Wang, Qi, primary, Shaw, David E., primary, and Poulikakos, Poulikos I., primary

Published
2023
Full Text
View/download PDF

49. Supplementary Movie 2 from ER Translocation of the MAPK Pathway Drives Therapy Resistance in BRAF-Mutant Melanoma

Author

Ojha, Rani, primary, Leli, Nektaria M., primary, Onorati, Angelique, primary, Piao, Shengfu, primary, Verginadis, Ioannis I., primary, Tameire, Feven, primary, Rebecca, Vito W., primary, Chude, Cynthia I., primary, Murugan, Sengottuvelan, primary, Fennelly, Colin, primary, Noguera-Ortega, Estela, primary, Chu, Charleen T., primary, Liu, Shujing, primary, Xu, Xiaowei, primary, Krepler, Clemens, primary, Xiao, Min, primary, Xu, Wei, primary, Wei, Zhi, primary, Frederick, Dennie T., primary, Boland, Genevieve, primary, Mitchell, Tara C., primary, Karakousis, Giorgos C., primary, Schuchter, Lynn M., primary, Flaherty, Keith T., primary, Zhang, Gao, primary, Herlyn, Meenhard, primary, Koumenis, Constantinos, primary, and Amaravadi, Ravi K., primary

Published
2023
Full Text
View/download PDF

50. Chemical Methods from PPT1 Promotes Tumor Growth and Is the Molecular Target of Chloroquine Derivatives in Cancer

Author

Rebecca, Vito W., primary, Nicastri, Michael C., primary, Fennelly, Colin, primary, Chude, Cynthia I., primary, Barber-Rotenberg, Julie S., primary, Ronghe, Amruta, primary, McAfee, Quentin, primary, McLaughlin, Noel P., primary, Zhang, Gao, primary, Goldman, Aaron R., primary, Ojha, Rani, primary, Piao, Shengfu, primary, Noguera-Ortega, Estela, primary, Martorella, Alessandra, primary, Alicea, Gretchen M., primary, Lee, Jennifer J., primary, Schuchter, Lynn M., primary, Xu, Xiaowei, primary, Herlyn, Meenhard, primary, Marmorstein, Ronen, primary, Gimotty, Phyllis A., primary, Speicher, David W., primary, Winkler, Jeffrey D., primary, and Amaravadi, Ravi K., primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results